Clinical Trial Update: Systemic and Central Inflammation in AD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial on systemic and central inflammation in Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Alzheimer Disease | Phase 2 | Status: RECRUITING